This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Seattle Genetics, Inc.. Active years: 2012-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2013
Title: The Innovations of Ezogelin Oflazoglu
Introduction
Ezogelin Oflazoglu is a notable inventor based in Bothell, WA (US). He has made significant contributions to the field of medicine, particularly in the treatment of Hodgkin's lymphoma. With a total of 2 patents, his work focuses on innovative therapies that combine traditional chemotherapy with advanced antibody-drug conjugates.
Latest Patents
Oflazoglu's latest patents include methods for the treatment of Hodgkin's lymphoma. These methods involve administering both a chemotherapeutic regimen and an antibody-drug conjugate compound to a subject in need thereof. This combination therapy represents a promising advancement in cancer treatment, aiming to improve patient outcomes.
Career Highlights
Ezogelin Oflazoglu is currently associated with Seattle Genetics, Inc., a company renowned for its pioneering work in cancer therapies. His role at the company allows him to collaborate with leading experts in the field, further enhancing his contributions to medical science.
Collaborations
Some of his notable coworkers include Eric Sievers and Hans-Peter Gerber. Their collective expertise contributes to the innovative environment at Seattle Genetics, Inc., fostering advancements in cancer treatment.
Conclusion
Ezogelin Oflazoglu's work exemplifies the intersection of innovation and medicine. His patents and collaborations highlight the importance of combining traditional and modern therapies in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile